{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:48:42Z","timestamp":1793782122732,"version":"4.6.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.nucmedbio.2015.06.007","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T00:41:57Z","timestamp":1435020117000},"page":"899-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Can adaptive threshold-based metabolic tumor volume (MTV) and lean body mass corrected standard uptake value (SUL) predict prognosis in head and neck cancer patients treated with definitive radiotherapy\/chemoradiotherapy?"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5438-9969","authenticated-orcid":false,"given":"Ozlem Ozkaya","family":"Akagunduz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7520-760X","authenticated-orcid":false,"given":"Recep","family":"Savas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Yalman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan","family":"Kocacelebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Esassolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0005","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00259-011-1789-x","article-title":"Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study","volume":"38","author":"Schinagl","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2214\/AJR.13.11013","article-title":"Prognostic value of pretreatment 18F-FDG PET\/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma","volume":"202","author":"Koyasu","year":"2014","journal-title":"AJR"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0015","doi-asserted-by":"crossref","first-page":"976","DOI":"10.2214\/AJR.10.4884","article-title":"Use of 18F-FDG PET\/CT as a predictive biomarker of outcome in patient with head and neck non-squamous cell carcinoma","volume":"197","author":"Imsande","year":"2011","journal-title":"AJR"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ijrobp.2008.10.060","article-title":"Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer","volume":"74","author":"La","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0025","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00259-012-2127-7","article-title":"Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy","volume":"39","author":"Kao","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0030","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1158\/1078-0432.CCR-08-3290","article-title":"Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography\/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer","volume":"15","author":"Chung","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/02841860903440270","article-title":"Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy","volume":"49","author":"Seol","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/annonc\/mds247","article-title":"Prognostic value of metabolic tumor volume measured by 18F-FDG PET\/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx","volume":"24","author":"Park","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1148\/radiology.213.2.r99nv37521","article-title":"Reevaluation of the standardized uptake value for FDG: variations within body weight and methods for correction","volume":"213","author":"Sugawara","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0050","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ijrobp.2010.01.057","article-title":"Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer","volume":"80","author":"Murphy","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.nucmedbio.2015.06.007_bb0055","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ijrobp.2004.06.254","article-title":"Defining a radiotherapy target with positron emmision tomography","volume":"60","author":"Black","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0060","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ijrobp.2007.07.2333","article-title":"Comparison of five segmentation tools for 18F-Fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer","volume":"69","author":"Schinagl","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0065","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1148\/rg.337125163","article-title":"Functional imaging for radiation treatment planning, response assessment, and adaptive therapy in head and neck cancer","volume":"33","author":"Bhatnagar","year":"2013","journal-title":"Radiographics"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00259-010-1688-6","article-title":"PET functional volume delineation: robustness and repeatability study","volume":"38","author":"Hatt","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1748-717X-5-76","article-title":"18F-FDG PET\/CT-based gross tumor volume definition for radiotherapy in head and neck cancer: a correlation study between suitable uptake value threshold and tumor parameters","volume":"5","author":"Kao","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0080","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0085","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1200\/JCO.20.5.1398","article-title":"Standardized uptake value of 2-[18F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy","volume":"20","author":"Allal","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0090","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0095","first-page":"983","article-title":"Use of PET for monitoring cancer therapy and for predicting outcome","volume":"46","author":"Weber","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0100","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1148\/radiology.189.3.8234714","article-title":"Standardized uptake value of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction","volume":"189","author":"Zasadny","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0105","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/00006231-199610000-00011","article-title":"Dependency of standardized uptake values of fluorine-18 fluorodeoxyglucose on body size: comparison of body surface area correction and lean body mass correction","volume":"17","author":"Kim","year":"1996","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2015.06.007_bb0110","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2967\/jnumed.113.136986","article-title":"Optimum lean body formulation for correction of standardized uptake value in PET imaging","volume":"55","author":"Tahari","year":"2014","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805115001055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805115001055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T11:29:20Z","timestamp":1566905360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805115001055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0969805115001055"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2015.06.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can adaptive threshold-based metabolic tumor volume (MTV) and lean body mass corrected standard uptake value (SUL) predict prognosis in head and neck cancer patients treated with definitive radiotherapy\/chemoradiotherapy?","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2015.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}